Collectively, our findings demonstrate that Pin1 promotes the recruitment of Tregs and activates CAFs by upregulating CCL3 via activation of the NF-κB pathway, thereby inhibiting immunotherapy in MSS CRC. The gene discussed is PIN1; the disease is Marinesco-Sjogren syndrome.